Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$680,076
+$27,960 QoQ
Shares Held
567
-20.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#3,481
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meadowbrook Advisors Group, LLC holds $7,833,012 across 7 Drug Manufacturers - General names. LLY ranks #5 (8.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
8,522 | $2,144,476 | |
| 2 | JNJ |
Johnson & Johnson
|
6,744 | $1,712,773 | |
| 3 | AMGN |
Amgen Inc
|
4,272 | $1,546,976 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,576 | $973,516 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
567 | $680,076 | |
| 6 | AZN |
Astrazeneca PLC
|
2,633 | $499,269 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,184 | $275,926 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $680,076 | 567 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $652,116 | 709 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $764,097 | 711 | Shares | Sole | 2026-03-11 | |
| No filing history on record for this holder in this stock. | ||||||